Literature DB >> 946511

Reduction of amphotericin B nephrotoxicity with mannitol.

J M Rosch, G J Pazin, P Fireman.   

Abstract

Amphotericin B in combination with mannitol was given to a patient who had mucocutaneous candidiasis and moderate renal insufficiency. Previously, amphotericin B alone had induced an abrupt increase in serum creatinine and urea nitrogen, but when mannitol was given concurrently there was no worsening of renal function. Thus, amphotericin B with mannitol appears to offer a less nephrotoxic but equally candicidal therapeutic regimen in the renal compromised patient requiring parenteral candicidal therapy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 946511

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  6 in total

Review 1.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

Review 2.  Amphotericin B nephrotoxicity.

Authors:  R Sabra; R A Branch
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

3.  Aspergillus granuloma of the trigeminal ganglion.

Authors:  C M Wiles; R S Kocen; L Symon; F Scaravilli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-05       Impact factor: 10.154

Review 4.  Mannitol.

Authors:  A R Nissenson; R E Weston; C R Kleeman
Journal:  West J Med       Date:  1979-10

Review 5.  Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity.

Authors:  Iman Karimzadeh; Hossein Khalili; Shadi Farsaei; Simin Dashti-Khavidaki; Mohammad Mahdi Sagheb
Journal:  Eur J Clin Pharmacol       Date:  2013-01-30       Impact factor: 2.953

6.  Caffeic acid phenethyl ester protects against amphotericin B induced nephrotoxicity in rat model.

Authors:  Atila Altuntaş; H Ramazan Yılmaz; Ayşegül Altuntaş; Efkan Uz; Murat Demir; Alparslan Gökçimen; Oğuzhan Aksu; Dilek Şenol Bayram; Mehmet Tuğrul Sezer
Journal:  Biomed Res Int       Date:  2014-06-16       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.